At the news
? NEUTRALIMPACT 3/10 EFFECT filed Mar 2, 2026 at 00:15 ET
Spyre Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This is a routine capital markets update with no immediate financial impact.
- Form EFFECT filed for Spyre Therapeutics, Inc. (SYRE)
- Effectiveness date: February 27, 2026
- Underlying registration is Form S-3 (shelf registration)
- No specific offering size, pricing, or securities type disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access